You've heard about the likes of Ozempic, Wegovy and Mounjaro, jabs which a growing number of people are taking in an attempt ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

A Chinese company has developed a new diabetes drug that could become a strong competitor to Ozempic and Monjauro as a weight ...

Khloé Kardashian has never shied away from sharing her health journey.

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could ...

Ozempic is an FDA-approved medication for people with type 2 diabetes. It’s often prescribed off-label for weight loss — that ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone. Ozempic for blood sugar control and Wegovy for weight loss both use different ...

A NEW weight loss jab that only needs to be taken once monthly leads to “substantial weight loss”, according to early trials.

Lizzo revealed on the 'Just Trish' podcast on June 19 that she has tried Ozempic and other GLP-1 drugs — which are ...

A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.

Study comparing bariatric surgery to GLP-1 medications shows 24% total weight loss from surgery versus 4.7% from injectables, ...